Tag: peripheral arterial bypass

Humacyte

Humacyte publish six-year outcomes in study of HAV for peripheral arterial...

Humacyte, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues and advanced tissue constructs and organ systems at commercial scale, today announced...